PORTFOLIO

StapleBio Inc. promotes the development of therapeutic drugs for rare diseases and other conditions through the development of drugs using its next-generation nucleic acid drug technology, Staple Nucleic Acid.

Global Vascular Co., Ltd. is a developer of a drug-eluting stent delivery system applied with nanotechnology, which achieves the world's first cutting-edge endovascular treatment for lower limb artery disease.

FerroptoCure Inc. aims to cure intractable cancers and other diseases through innovative drug discovery utilizing ferroptosis, and to contribute to the creation of a society in which everyone can live in peace and health.